Niagen Bioscience (NAGE) Other Operating Expenses (2013 - 2026)

Niagen Bioscience (NAGE) has reported Other Operating Expenses for 16 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses changed N/A year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $30.2 million (up 215.5% YoY), while the FY2025 annual figure was $33.5 million, up 457.23% from the prior year.
• Other Operating Expenses declined to $4.8 million in Q1 2026 per NAGE's latest filing, from $8.4 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $8.8 million in Q3 2025 and bottomed at -$17.3 million in Q4 2022.
• Historically, Other Operating Expenses has averaged $2.8 million across 5 years, with a median of $6.0 million in 2023.
• Annual changes were most pronounced in 2022 — Other Operating Expenses sank 83.05% — and 2023, when it surged 630.43%.
• Niagen Bioscience's Other Operating Expenses stood at -$17.3 million in 2022, then rose by 13.53% to -$15.0 million in 2023, then surged by 108.79% to $1.3 million in 2024, then soared by 541.14% to $8.4 million in 2025, then plunged by 43.07% to $4.8 million in 2026.
• Business Quant data shows NAGE's Other Operating Expenses at $4.8 million in Q1 2026, $8.4 million in Q4 2025, and $8.8 million in Q3 2025.